五色多重荧光免疫组化染色试剂盒(鼠兔通用二抗)
货号-规格 | 货期 | 价格 | 数量 |
abs50013-20T | 现货 | ¥5890.00 | - + |
abs50013-100T | 现货 | ¥22410.00 | - + |
温馨提示:本产品仅作科研实验使用,不支持临床等研究 |
- 实验方法 实验条件
共 0 张,还能上传 8 张 提交
- 提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要咨询”按钮填写您的疑问。
提交不成功?请联系info@absin.cn。
- 微波修复抗原每一轮染色都要做吗?可以用抗体洗脱液替代吗?抗体洗脱液用在哪个步骤?
- 染第一个抗体之前做抗原修复,是为了使被石蜡或者固定剂封闭的抗原决定簇重新暴露出来,使得抗体能够识别到抗原;在染后面每一个抗体之前的抗原修复,目的是为了去除掉上一轮染色的抗体和残留没有结合上的染料,其实更准确的叫法是“抗体洗脱”,也就是说第一次的抗原修复是真正的抗原修复,后面的抗原修复实际上是“抗体洗脱”,“抗体洗脱”可以用抗体洗脱液(abs994)替换,特别是细胞、冰冻切片或者骨样本,但第一次抗原修复不能被抗体洗脱液替代,冰冻切片可以不进行抗原修复,染色效果欠佳时,可以考虑尝试进行抗原修复,推荐冰冻切片快速抗原修复液(5×)(abs9207)。
- 脱蜡水合步骤中“10%中性福尔马林浸片10min,灭菌水洗片1min,重复3次”目的是什么?我们以前做石蜡切片的时候没有这一步。
- 这是后固定的步骤,固定充分的组织可以省略此步。
- 做好的多色片子,无法进行及时扫描,该如何保存?
- 需要避光防震,在4℃条件下保存
- 有详细的实验操作流程吗?
- 有的,我们有完整的操作视频,您可以点击链接观看完整视频。
- 样本可以做成冰冻切片吗?
- 可以的。抗原修复步骤不推荐用加热的方法,推荐用抗体洗脱液(abs994)
- 所有操作要避光吗?
- 不需要,在常规环境下操作就可以,染料的荧光强度很高。
- 抗体修复液每一轮修复都要更换吗?
- 是的,每一轮都要根据抗体选择相应的修复液。
- 染料的选择会影响后染色吗,有共定位的话怎么办?
- 共定位的情况,我们可以通过单一通道观察来更好的检测各指标的分布情况,染料不会对染色有影响,串色的情况需要预实验做充足,包括抗体稀释比例,染料与放大液比例,修复条件的确定。
- 多色用的一二抗各是什么种属?
- 多色的优势在于一二抗种属无需特别要求,一抗根据样本种属选择既可,二抗根据一抗选择即可,多个抗体组合,种属不会有影响。
- 抗体洗脱和微波修复哪种方式洗脱效果更好?
- 微波修复洗脱更稳定,抗体洗脱液对大多数抗体都管用,难洗的抗体延长洗脱时间就可以啦!
- 实验用时真的一天能做完吗?
- 相比普通的组织荧光实验,我们一抗的孵育时间只需室温30min,二抗和信号放大步骤只需孵育10min,能大大节约时间,五色左右可在一天内做完。
- 多色样本的寄送有条件限制吗?
- 正常的石蜡切片和组织芯片很稳定,只要防震盒常温运输即可,冰冻切片的话,需要干冰低温运输。
- 我的组织还有GFP蛋白,给结果的时候能排除干扰吗?
可以的,结果分析的时候可以避免绿色通道,分析软件赋予的颜色是伪彩色,可以更换其他颜色。
- 我这边提供抗体的话,抗体需要满足什么条件吗?
抗体需要要满足IHC的实验应用,各品牌供应商都会提供相应的实验验证的,爱必信组化抗体经过严格实验验证,是不错的选择。
- 如果我能提供抗体给你们做服务的话,需要的抗体量是多少?
需要的抗体量要根据样本数来,但一般来讲,50-100ul的抗体足够完成预实验+正式实验了。
- 在指标与染料的搭配以及染色顺序上,有什么规律吗?
- 并没有一个特别的线性关系,和蛋白的种类、表达量以及修复条件都有关系,所以会多因素考虑,多尝试,预实验很重要。
- TSA技术原理中有抗体洗脱的步骤,但是在你们的试剂盒步骤说明中却没有?
试剂盒步骤中的抗原修复过程就是抗体洗脱过程。
- B细胞、T细胞、DC细胞常用maker能推荐下吗?
T细胞:CD3、CD4、CD8、FoxP3(再细化还有:GranzymeB、PD-1、TIM-3、CD45)
B细胞:CD19 ;
DC细胞:CD8α、CD11b
- 荧光染料激发光和发射光波长分别是多少?
染料名称
保存温度
波长
相似荧光染料
激发波长
发射波长
DAPI
-20℃
360
461
DAPI
TSA单色荧光染料480
430
480
Opal480
TSA单色荧光染料520
490
520
FITC/AF488/Opal520
TSA单色荧光染料540
520
540
AF514/Opal540
TSA单色荧光染料570
550
570
CY3/AF555/Opal570
TSA单色荧光染料620
590
620
AF594/Opal620
TSA单色荧光染料650
640
660
AF610/Opal650
TSA单色荧光染料700
682
702
AF680/CY5.5/Opal690
TSA单色荧光染料770
740
780
Opal780
- Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer
Canhui Cao, Qian Xu, Zhixian Zhu, Miaochun Xu, Ye Wei, Shitong Lin, Sheng Cheng, Wenhua Zhi, Ping Hong, Xingyu Huang, Da Lin, Gang Cao, Yifan Meng, Ping Wu, Ting Peng , Juncheng Wei, Wencheng Ding, Xiaoyuan Huang, WingKin Sung, Gang Chen, Peng Wu
Cancer Letters. 2024 Apr 28 .
影响因子: 9.7
- Targeting SIRT4/TET2 Signaling Alleviates Human Keratinocyte Senescence by Reducing 5-hydroxymethylcytosine Loss
Yi Yi , Yuchang Wang , Yiping Wu , Yukun Liu
Laboratory Investigation. 2024 Feb 01 ; 2
影响因子: 5
- Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer
He Xing, Peng Yaorong, He Gui, Ye Huilin, Liu Liqiang, Zhou Qixian, Shi Juanyi, Fu Sha, Wang Jie, Zhou Zhenyu, Li Wenbin
Journal of Translational Medicine. 2023 Oct 12 .
影响因子: 7.4
- The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity
Xuedan Sun, Lifang He, Hong Liu, Rick Francis Thorne, Taofei Zeng, Liu Liu, Bo Zhang, Miao He, Yabin Huang, Mingyue Li, Enyi Gao, Mengyao Ma, Cheng Cheng, Fanzheng Meng, Chuandong Lang, Hairui Li, Wanxiang Xiong, Shixiang Pan, Delong Ren, Bingyi Dang, Yi Yang, Mian Wu, Lianxin Liu
Cell Metabolism. 2023 Aug 04 .
影响因子: 29
- An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma
Mao Zhang, Yingying Huang, Jiaomeng Pan, Chen Sang, Youpei Lin, Liangqing Dong, Xia Shen, Yingcheng Wu, Guohe Song, Shuyi Ji, Fen Liu, Mengcheng Wang, Yuyan Zheng, Sirui Zhang, Zefeng Wang, Jianke Ren, Daming Gao, Jian Zhou, Jia Fan, Wu Wei, Jian Lin, Qiang Gao
Cancer Discovery. 2023 Jul 24 .
影响因子: 28.2
- ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
Xin Shiyong, Liu Xiang, Li Ziyao, Sun Xianchao, Wang Rong, Zhang Zhenhua, Feng Xinwei, Jin Liang, Li Weiyi, Tang Chaozhi, Mei Wangli, Cao Qiong, Wang Haojie, Zhang Jianguo, Feng Lijin, Ye Lin
Experimental Hematology & Oncology. 2023 May 23 .
影响因子: 8.593
- 敲低序列相似家族172成员A抑制肝癌细胞增殖和糖酵解
刘红; 黄亚彬; 刘连新
中国生物化学与分子生物学报. 2023 Apr 02 .
- ICOS/ICOSLG and PD-1 Co-Expression is Associated with the Progression of Colorectal Precancerous- Carcinoma Immune Microenvironment
Yu Zhang, Xue-Li Wang, Jing-Jing Liu, Zhen-Yuan Qian, Zheng-Yang Pan, Ni-Ping Song, Hui-Yan Chen, Wei Zhang, Xin Zhang
Journal of Inflammation Research. 2023 Mar 07 .
影响因子: 4.631
- Increased NKG2A+CD8+ T-cell exhaustion in patients with adenomyosis
Wei Liu, Shuman Sheng, Chendi Zhu, Changzhong Li, Yonghui Zou, Chunrun Yang, Zi-Jiang Chen, Fei Wang, Xue Jiao
Mucosal Immunology. 2023 Feb 23 .
影响因子: 8.701
- Extracellular Vesicle–Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis
Wang Fang, Niu Yuequn, Chen Kelie, Yuan Xiaoyu, Qin Yuheng, Zheng Fang, Cui Zhenyan, Lu Weiguo, Wu Yihua, Xia Dajing
Cancer Immunology Research. 2023 Feb 03 .
影响因子: 12.02
- Plasma-derived exosomes contributes to Endothelial-to-mesenchymal transition in moyamoya disease
Jilan Liu, Chao Chen, Xianyun Qin, Yan Lu, Bin Zhang, Feng Jin
Research Square. 2023 Jan 04 .
- Intra-Tumoral Secondary Follicle-like Tertiary Lymphoid Structures Are Associated with a Superior Prognosis of Overall Survival of Perihilar Cholangiocarcinoma
Fa-Peng Zhang, Ke Zhu, Tai-Feng Zhu, Chao-Qun Liu, Hong-Hua Zhang, Lei-Bo Xu, Gang Xiao, Chao Liu
Cancers. 2022 Dec 12 .
影响因子: 6.575
- A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma
Zhang, Chao, Shen, Hongru, Yang, Tielong, Li, Ting, Liu, Xinyue, Wang, Jin, Liao, Zhichao, Wei, Junqiang, Lu, Jia, Liu, Haotian, Xiang, Lijie, Yang, Yichen, Yang, Meng, Wang, Duan, Li, Yang, Xing, Ruwei, Teng, Sheng, Zhao, Jun, Yang, Yun, Zhao, Gang, Chen, Kexin, Li, Xiangchun, Yang, Jilong
Nature Communications. 2022 Nov 25 .
影响因子: 17.694
- TRIM22 orchestrates the proliferation of glioblastomas and the benefits of TMZ by coordinating the modification and degradation of RIG-I
Xiaowei Fei,Xiuquan Wu, Ya-Nan Dou, Kai Sun, Qingdong Guo, Lei Zhang, Sanzhong Li, Jialiang Wei, Yu Huan, Xin He, Zhou Fei
Molecular Therapy-Oncolytics. 2022 Aug 25 .
影响因子: 6.311
- Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
Xin Guan, Liping Sun, Yuting Shen, Fengshan Jin, Xiaowan Bo, Chunyan Zhu, Xiaoxia Han, Xiaolong Li, Yu Chen, Huixiong Xu, Wenwen Yue
Nat Commun. 2022 May 20 ; 1
影响因子: 17.694
- Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma
Haitang Yang, Beibei Sun, Liwen Fan, Wenyan Ma, Ke Xu, Sean R. R. Hall, Zhexin Wang, Ralph A. Schmid, Ren-Wang Peng, Thomas M. Marti, Wen Gao, Jianlin Xu, Weiwei Yang, Feng Yao
Theranostics. 2022 Mar 28 ; 7
影响因子: 11.556
- SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer
Tian-Jiao Li, Kai-Zhou Jin, Hao Li, Long-Yun Ye, Peng-Cheng Li, Bruce Jiang, Xuan Lin, Zhen-Yu Liao, Hui-Ru Zhang, Sai-Meng Shi, Meng-Xiong Lin, Qing-Lin Fei, Zhi-Wen Xiao, Hua-Xiang Xu, Liang Liu, Xian-Jun Yu, Wei-Ding Wu
Cancer Letters. 2022 Jan 22 .
影响因子: 8.679
- The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy
Gang Wei, Honglin Sun, Kai Dong,, Xiaoyong Hu, Linhui Wang, Junli Liu
Cell Metabolism. 2021 Oct 05 .
影响因子: 27.287
- 雷公藤甲素对急性高眼压大鼠视网膜神经节细胞的保护作用
汪新芳; 马滕
中国医药导报. 2021 Jun 25 ; 18
- Neoadjuvant Chemotherapy Combined with Camrelizumab for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Cohort Study
YY Chen, PP Wang, Y Hu, Y Yuan, YS Yang, HS Shi…
.